Ginkgo Bioworks Holdings
DNA· Manufacturing· Fiscal year ends in December
CEO pay in FY2025
Jason Kelly is the CEO of Ginkgo Bioworks Holdings and was paid $5.7M in FY2025 (Dec), up 364%.
PayNo stock prices for these years
Executives4
See all- 1Jason KellyChief Executive OfficerFY2025
- 2Reshma ShettyPresident & Former Chief Operating OfficerFY2025
- 3Steven CoenChief Financial OfficerFY2025
- 4Mark DmytrukFormer Chief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allGinkgo Bioworks Holdings paid its 4 named executives $10.9M in total in FY2025 (Dec). CEO Jason Kelly was paid $5.7M of that.
| Name | |||
|---|---|---|---|
| Jason KellyChief Executive Officer | |||
| Reshma ShettyPresident & Former Chief Operating Officer | |||
| Steven CoenChief Financial Officer | Not disclosed | Not disclosed | |
| Mark DmytrukFormer Chief Financial Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers18
See allThe comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board5
See all- Jason KellyDirector · 17 yr on the boardNot independent—Paid as an executive
- Reshma ShettyDirector · 17 yr on the boardNot independent—Paid as an executive
- Christian HenryDirector · 9 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive
- Harry E. SloanDirector · 4 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive
- Sri KosuriDirector · 1 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 29, 2026 | FY2025 |
| Annual report | 10-K | Feb 26, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 29, 2025 | FY2024 |
| Annual report | 10-K | Feb 25, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 29, 2024 | FY2023 |
| Annual report | 10-K | Feb 29, 2024 | FY2023 |